Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 9.34% is 43% above its 5-year average of 6.51%, near the high end of its 5-year range (0.39%–9.34%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.86% above its 12-month average of 8.82%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.34%.
DEBT TO ASSETS RATIO
9.34%
DEBT TO ASSETS RATIO AVG TTM
8.82%
DEBT TO ASSETS RATIO AVG 3Y
7.75%
DEBT TO ASSETS RATIO AVG 5Y
6.51%
DEBT TO ASSETS RATIO AVG 10Y
11.24%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+5.86%
CURRENT VS 3Y AVG
+20.48%
CURRENT VS 5Y AVG
+43.39%
CURRENT VS 10Y AVG
-16.91%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 806 covered companies
CURRENT VS SECTOR MEDIAN
+10279.36%
vs the sector median at left
MaxCyte, Inc.
Market Cap
$112.65M
Debt to Assets Ratio
9.34%
TTM Avg
8.82%
3Y Avg
7.75%
5Y Avg
6.51%
Market Cap
$112.85M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$112.20M
Debt to Assets Ratio
0.21%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$112.05M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$114.14M
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$115.46M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$116.04M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.49M
Debt to Assets Ratio
0.65%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MaxCyte, Inc. (MXCT) | $112.65M | 9.34% | 8.82% | 7.75% | 6.51% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $112.85M | 0.09% | N/A | N/A | N/A |
| Foghorn Therapeutics Inc. (FHTX)vs › | $112.20M | 0.21% | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $112.05M | 0.01% | N/A | N/A | N/A |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.14M | 0.64% | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $111.14M | 0.00% | N/A | N/A | N/A |
| Genelux Corporation (GNLX)vs › | $115.46M | 0.09% | N/A | N/A | N/A |
| Caribou Biosciences, Inc. (CRBU)vs › | $116.04M | 0.19% | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $109.49M | 0.65% | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.80M | 0.00% | N/A | N/A | N/A |
Debt/Assets
9.3%
Debt/Equity
0.11
Current Ratio
12.26
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 9.34% |
| 2026-03-31 | 8.99% |
| 2025-12-31 | 8.86% |
| 2025-09-30 | 8.51% |
| 2025-06-30 | 8.42% |
| 2025-03-31 | 8.18% |
| 2024-12-31 | 7.53% |
| 2024-09-30 | 7.37% |
| 2024-06-30 | 7.37% |
| 2024-03-31 | 7.23% |
| 2023-12-31 | 6.99% |
| 2023-09-30 | 6.03% |
| 2023-06-30 | 5.98% |
| 2023-03-31 | 5.77% |
| 2022-12-31 | 5.61% |
| 2022-09-30 | 5.25% |
| 2022-06-30 | 5.00% |
| 2022-03-31 | 4.55% |
| 2021-12-31 | 2.00% |
| 2021-09-30 | 0.39% |
| 2021-06-30 | 1.31% |
| 2021-03-31 | 1.99% |
| 2020-12-31 | 13.45% |
| 2020-06-30 | 13.06% |
| 2019-12-31 | 24.05% |
| 2019-09-30 | 24.05% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 20.84% |
| 2018-09-30 | 20.84% |
| 2018-06-30 | 18.85% |
| 2018-03-31 | 18.85% |
| 2017-12-31 | 16.02% |
| 2017-09-30 | 16.01% |
| 2017-06-30 | 13.58% |
| 2017-03-31 | 13.55% |
| 2016-12-31 | 31.15% |
| 2016-09-30 | 31.06% |
| 2016-06-30 | 30.41% |
| 2016-03-31 | 30.33% |
| 2015-12-31 | 78.80% |
| 2015-09-30 | 78.54% |
| 2015-06-30 | 30.10% |
| 2015-03-31 | 86.40% |
| 2014-12-31 | 77.98% |
| 2014-09-30 | 79.48% |
